{
  "id": 181308,
  "name": "MALLINCKRODT PHARMACEUTICALS",
  "slug": "mallinckrodt-pharmaceuticals",
  "state": "MO",
  "description": "Mallinckrodt Pharmaceuticals manufactures specialty products and diagnostics",
  "totalSpending": 1380000,
  "filings": 18,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 240000
    },
    {
      "year": 2019,
      "income": 240000
    },
    {
      "year": 2020,
      "income": 320000
    },
    {
      "year": 2021,
      "income": 320000
    },
    {
      "year": 2022,
      "income": 260000
    }
  ],
  "firms": [
    "TARPLIN, DOWNS & YOUNG, LLC"
  ],
  "lobbyists": [
    "RAISSA DOWNS",
    "JENNIFER YOUNG",
    "MICHELLE EASTON",
    "ELIZABETH MURRAY",
    "CHARLOTTE IVANCIC",
    "PAMELA SMITH",
    "EMILY MURRY",
    "KIMBERLY BRANDT",
    "MARGARET JOSEPH"
  ],
  "issues": [
    "HCR",
    "TAX",
    "BUD",
    "MMM"
  ],
  "sampleDescriptions": [
    "prescription drug abuse and deterrence, non-interference\nPL 114-255 - 21st Century Cures, implementation\nMulti-modal analgesics\nS. 771 - Improving Access to Affordable Prescription Drugs Act\nS. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017\nStopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017\nS. 469 - Affordable and Safe Prescription Drug Importation act\nH.R. 749 - Lower Drug Costs Through Competition Act\nH.R. 2430 - FDA Reauthorization Act of 2017\nH.R. 3921 - Healthy Kids Act\nS. 1827 - Kids Act of 2017\nS. 260/H.R. 849 - Protecting Seniors' Access to Medicare Act of 2017\nH.R. 6 - SUPPORT for Patients and Communities Act\nS. 3120 - HEAL Substance Use Disorders Act\nS. 2680 - Opioid Crisis Response Act\nS. 2852 - Pandemic and All Hazards Preparedness Act",
    "H.R. 1- Tax Cuts and Jobs Act",
    "budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018",
    "prescription drug abuse and deterrence, non-interference\nPL 114-255 - 21st Century Cures, implementation\nMulti-modal analgesics\nS. 771 - Improving Access to Affordable Prescription Drugs Act\nS. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017\nStopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017\nS. 469 - Affordable and Safe Prescription Drug Importation act\nH.R. 749 - Lower Drug Costs Through Competition Act\nH.R. 2430 - FDA Reauthorization Act of 2017\nH.R. 3921 - Healthy Kids Act\nS. 1827 - Kids Act of 2017\nS. 260/H.R. 849 - Protecting Seniors' Access to Medicare Act of 2017\nH.R. 6 - SUPPORT for Patients and Communities Act\nS. 3120 - HEAL Substance Use Disorders Act\nS. 2680 - Opioid Crisis Response Act\nS. 2852 - Pandemic and All Hazards Preparedness Act \nS. 3282 - DEA Clearinghouse Act of 2018",
    "budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018\nH.R. 6157 - HHS appropriations and continuing resolution",
    "budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018\nH.R. 6157 - HHS appropriations and continuing resolution\nH.R. 695 - Department of Defense Appropriations Act",
    "Medicaid drug rebate program",
    "prescription drug abuse and deterrence, non-interference, opioids\nH.R. 269 - PAHPA Reauthorization of 2019\n\nno specific bills, drug pricing and innovation",
    "budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations\nH.J.Res. 31 - Consolidated Appropriations Act, 2019",
    "debt ceiling, appropriations\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act",
    "prescription drug abuse and deterrence, non-interference, opioids\nH.R. 269 - PAHPA Reauthorization of 2019\nS. 1416 - Affordable Prescriptions For Patients Act of 2019 \nS. 1895 - Lower Health Care Costs Act\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\n\nno specific bills, drug pricing and innovation",
    "prescription drug abuse and deterrence, non-interference\nH.R. 269 - PAHPA Reauthorization of 2019\nS. 1416 - Affordable Prescriptions For Patients Act of 2019 \nS. 1895 - Lower Health Care Costs Act\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\nS. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act\nS. 3129 - Lower Costs, More Cures Act of 2019\n\nno specific bills, drug pricing and innovation",
    "debt ceiling, appropriations\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\nH.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act",
    "prescription drug abuse and deterrence, non-interference\nH.R. 269 - PAHPA Reauthorization of 2019\nS. 1416 - Affordable Prescriptions For Patients Act of 2019 \nS. 1895 - Lower Health Care Costs Act\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\nS. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act\nS. 3129 - Lower Costs, More Cures Act of 2019\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020\nH.R. 6201 - Families First Coronavirus Response Act\nS. 3548 - CARES Act\n\nno specific bills, drug pricing and innovation",
    "prescription drug abuse and deterrence, non-interference\nH.R. 269 - PAHPA Reauthorization of 2019\nS. 1416 - Affordable Prescriptions For Patients Act of 2019 \nS. 1895 - Lower Health Care Costs Act\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\nS. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act\nS. 3129 - Lower Costs, More Cures Act of 2019\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020\nH.R. 6201 - Families First Coronavirus Response Act\nS. 3548 - CARES Act\nH.R. 6800 - The Heroes Act\n\nno specific bills, drug pricing and innovation",
    "debt ceiling, appropriations\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\nH.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act\nH.R. 8337 - Continuing Appropriations Act of 2021",
    "Medicaid drug rebate program\nMedicaid Value Based Payment rule\nH.R. 133 - Consolidated Appropriations Act, 2021",
    "prescription drug abuse and deterrence, non-interference\nH.R. 269 - PAHPA Reauthorization of 2019\nS. 1416 - Affordable Prescriptions For Patients Act of 2019 \nS. 1895 - Lower Health Care Costs Act\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\nS. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act\nS. 3129 - Lower Costs, More Cures Act of 2019\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020\nH.R. 6201 - Families First Coronavirus Response Act\nS. 3548 - CARES Act\nH.R. 6800 - The Heroes Act\nH.R. 133 - Consolidated Appropriations Act, 2021\n\nno specific bills, drug pricing and innovation",
    "debt ceiling, appropriations\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\nH.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act\nH.R. 8337 - Continuing Appropriations Act of 2021\nH.R. 133 - Consolidated Appropriations Act, 2021",
    "deficit reduction, appropriations\nS. Con. Res. 5 (117)"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022
  ],
  "growthRate": 8,
  "trajectory": "stable",
  "yearsActive": 5,
  "avgAnnualSpending": 276000,
  "peakYear": 2020,
  "lobbyistCount": 9,
  "firmCount": 1,
  "issueCount": 4,
  "industry": "healthcare"
}